Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Bladder Cancer

  Free Subscription


1 Asia Pac J Clin Nutr
1 Biomed Res Int
1 Biosci Rep
1 BJU Int
1 BMC Med Inform Decis Mak
1 Cancer Cell Int
1 Cancer Immunol Immunother
1 Cancer Sci
1 Cancer Treat Res Commun
1 Cell Death Discov
1 Clin Transl Oncol
2 Curr Opin Urol
1 Eur J Surg Oncol
4 Eur Urol
1 Front Oncol
1 Int Braz J Urol
1 Int J Biol Markers
1 Int J Urol
1 J Cell Mol Med
1 J Exp Clin Cancer Res
2 J Urol
1 Jpn J Clin Oncol
1 Nat Rev Urol
1 Scand J Urol
1 Stem Cells Int
1 Theranostics
6 Transl Androl Urol
2 Urol Oncol
1 World J Urol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Asia Pac J Clin Nutr

  1. HE C, Li B, Huang L, Teng C, et al
    Gut microbial composition changes in bladder cancer patients: A case-control study in Harbin, China.
    Asia Pac J Clin Nutr. 2020;29:395-403.
    PubMed         Abstract available

    Biomed Res Int

  2. HUA H, Gao Y, Lin J, Hou F, et al
    Quantitative Analysis of Enhanced Computed Tomography in Differentiating Cystitis Glandularis and Bladder Cancer.
    Biomed Res Int. 2020;2020:4930621.
    PubMed         Abstract available

    Biosci Rep

  3. SHEN P, He X, Lan L, Hong Y, et al
    Identification of Cell Division Cycle 20 as a Candidate Biomarker and Potential Therapeutic Target in Bladder Cancer Using Bioinformatics Analysis.
    Biosci Rep. 2020 Jul 17. pii: 225826. doi: 10.1042/BSR20194429.
    PubMed         Abstract available

    BJU Int

  4. OH JJ, Lee S, Ku JH, Kwon TG, et al
    Oncological outcome according to attainment of pentafecta after robot assisted radical cystectomy among bladder cancer patients using KORARC database (730 multicenter robot radical cystectomy database).
    BJU Int. 2020 Jul 18. doi: 10.1111/bju.15178.
    PubMed         Abstract available

    BMC Med Inform Decis Mak

  5. YIN PN, Kc K, Wei S, Yu Q, et al
    Histopathological distinction of non-invasive and invasive bladder cancers using machine learning approaches.
    BMC Med Inform Decis Mak. 2020;20:162.
    PubMed         Abstract available

    Cancer Cell Int

  6. XU N, Ke ZB, Lin XD, Chen YH, et al
    Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis.
    Cancer Cell Int. 2020;20:302.
    PubMed         Abstract available

    Cancer Immunol Immunother

  7. TEMIZ MZ, Colakerol A, Ulus I, Kilic E, et al
    Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report.
    Cancer Immunol Immunother. 2020 Jul 22. pii: 10.1007/s00262-020-02673.
    PubMed         Abstract available

    Cancer Sci

  8. IDE H, Goto T, Teramoto Y, Mizushima T, et al
    FOXO1 inactivation induces cisplatin resistance in bladder cancer.
    Cancer Sci. 2020 Jul 17. doi: 10.1111/cas.14557.
    PubMed         Abstract available

    Cancer Treat Res Commun

  9. OGAWA K, Shimizu Y, Uketa S, Utsunomiya N, et al
    Prognosis of patients with muscle invasive bladder cancer who are intolerable to receive any anti-cancer treatment.
    Cancer Treat Res Commun. 2020;24:100195.
    PubMed         Abstract available

    Cell Death Discov

  10. CHENG S, Jiang Z, Xiao J, Guo H, et al
    The prognostic value of six survival-related genes in bladder cancer.
    Cell Death Discov. 2020;6:58.
    PubMed         Abstract available

    Clin Transl Oncol

  11. ZHANG JJ, Cai LJ, Pang K, Dong Y, et al
    Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo.
    Clin Transl Oncol. 2020 Jul 20. pii: 10.1007/s12094-020-02455.
    PubMed         Abstract available

    Curr Opin Urol

  12. MORI K, Mostafaei H, Abufaraj M, Yang L, et al
    Smoking and bladder cancer: review of the recent literature.
    Curr Opin Urol. 2020 Jul 20. doi: 10.1097/MOU.0000000000000804.
    PubMed         Abstract available

  13. EINERHAND SMH, van Gennep EJ, Mertens LS, Hendricksen K, et al
    18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
    Curr Opin Urol. 2020 Jul 20. doi: 10.1097/MOU.0000000000000798.
    PubMed         Abstract available

    Eur J Surg Oncol

  14. ZHANG H, Wang H, Zhu M, Xu Z, et al
    Implementation of enhanced recovery after surgery in patients undergoing radical cystectomy: A retrospective cohort study.
    Eur J Surg Oncol. 2020;46:202-208.
    PubMed         Abstract available

    Eur Urol

  15. VAN RHIJN BWG, Mertens LS, Mayr R, Bostrom PJ, et al
    FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?(dagger).
    Eur Urol. 2020 Jul 15. pii: S0302-2838(20)30531.
    PubMed         Abstract available

  16. WITJES JA, Ribal MJ, van der Heijden AG
    Reply to Francesco Montorsi, Marco Bandini, Alberto Briganti, et al. Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. Eur Urol. In press: Ca
    Eur Urol. 2020 Jul 18. pii: S0302-2838(20)30538.

  17. MARIAPPAN P, Johnston A, Padovani L, Clark E, et al
    Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Eur Urol. 2020 Jul 17. pii: S0302-2838(20)30511.
    PubMed         Abstract available

  18. ROBERTSON AG, Groeneveld CS, Jordan B, Lin X, et al
    Identification of Differential Tumor Subtypes of T1 Bladder Cancer.
    Eur Urol. 2020 Jul 16. pii: S0302-2838(20)30508.
    PubMed         Abstract available

    Front Oncol

  19. WANG C, Yang Y, Yin L, Wei N, et al
    Novel Potential Biomarkers Associated With Epithelial to Mesenchymal Transition and Bladder Cancer Prognosis Identified by Integrated Bioinformatic Analysis.
    Front Oncol. 2020;10:931.
    PubMed         Abstract available

    Int Braz J Urol

  20. WROCLAWSKI ML, Baccaglini WRC, Pazeto CL, Henriques LEB, et al
    Bladder pseudo-tumor: case report of vesical tamm-horsfall protein deposit.
    Int Braz J Urol. 2020;46:477-480.

    Int J Biol Markers

  21. DING D, Chen M, Xiao X, Cao P, et al
    Novel serum peptide model revealed by MALDI-TOF-MS and its diagnostic value in early bladder cancer.
    Int J Biol Markers. 2020 Jul 23:1724600820935473. doi: 10.1177/1724600820935473.
    PubMed         Abstract available

    Int J Urol

  22. TANAKA H
    Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision.
    Int J Urol. 2020 Jul 21. doi: 10.1111/iju.14314.

    J Cell Mol Med

  23. LI S, Zhu H, Chen H, Xia J, et al
    Glucose promotes epithelial-mesenchymal transitions in bladder cancer by regulating the functions of YAP1 and TAZ.
    J Cell Mol Med. 2020 Jul 17. doi: 10.1111/jcmm.15653.
    PubMed         Abstract available

    J Exp Clin Cancer Res

  24. ZHAN Y, Zhang L, Yu S, Wen J, et al
    Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/beta-catenin signaling pathway in bladder cancer.
    J Exp Clin Cancer Res. 2020;39:136.
    PubMed         Abstract available

    J Urol

  25. TAN WS, Kelly JD
    Editorial Comment.
    J Urol. 2020;204:56-57.
    PubMed         Abstract available

  26. SHKOLYAR E, Mach KE, Liao JC
    Editorial Comment.
    J Urol. 2020;204:56.

    Jpn J Clin Oncol

  27. KITAMURA H, Hinotsu S, Tsukamoto T, Shibata T, et al
    Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.
    Jpn J Clin Oncol. 2020 Jul 23. pii: 5874842. doi: 10.1093.
    PubMed         Abstract available

    Nat Rev Urol

  28. VAN PUFFELEN JH, Keating ST, Oosterwijk E, van der Heijden AG, et al
    Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer.
    Nat Rev Urol. 2020 Jul 16. pii: 10.1038/s41585-020-0346.
    PubMed         Abstract available

    Scand J Urol

    Cystoscopic surveillance for bladder cancer: Learning the lessons forced upon us by the Covid-19 pandemic.
    Scand J Urol. 2020 Jul 21:1-2. doi: 10.1080/21681805.2020.1794956.

    Stem Cells Int

  30. GAO Q, Zheng J, Ni Z, Sun P, et al
    The m(6)A Methylation-Regulated AFF4 Promotes Self-Renewal of Bladder Cancer Stem Cells.
    Stem Cells Int. 2020;2020:8849218.
    PubMed         Abstract available


  31. LIN T, Zhang Q, Yuan A, Wang B, et al
    Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment.
    Theranostics. 2020;10:7683-7696.
    PubMed         Abstract available

    Transl Androl Urol

    Editorial comment: the effect of neoadjuvant chemotherapy on tumour downstaging and outcomes in patients with muscle invasive bladder cancers.
    Transl Androl Urol. 2020;9:977-980.

  33. KOGA F
    Will chemoradiation-based bladder-sparing therapy become a standard of care for muscle-invasive bladder cancer?
    Transl Androl Urol. 2020;9:981-982.

  34. MAO W, Xie J, Wu Y, Wu Z, et al
    Cost-effectiveness analysis of two kinds of bladder cancer urinary diversion: Studer versus Bricker.
    Transl Androl Urol. 2020;9:1113-1119.
    PubMed         Abstract available

  35. MOGOS H, Eriksson E, Styrke J, Sherif A, et al
    Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis-results of a single centre
    Transl Androl Urol. 2020;9:1062-1072.
    PubMed         Abstract available

  36. LIPUNOVA N, Wesselius A, Cheng KK, van Schooten FJ, et al
    Gene-environment interaction with smoking for increased non-muscle-invasive bladder cancer tumor size.
    Transl Androl Urol. 2020;9:1329-1337.
    PubMed         Abstract available

  37. ZHAO C, Pan Y, Wang Y, Li Y, et al
    A novel cell-free single-molecule unique primer extension resequencing (cf-SUPER) technology for bladder cancer non-invasive detection in urine.
    Transl Androl Urol. 2020;9:1222-1231.
    PubMed         Abstract available

    Urol Oncol

  38. ALFANO M, Pederzoli F, Bandini M, Necchi A, et al
    The new era of precision urobiome: RE: "Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study" by Chipollini et al.
    Urol Oncol. 2020 Jul 16. pii: S1078-1439(20)30299.

  39. DEUKER M, Stolzenbach LF, Colla Ruvolo C, Nocera L, et al
    Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer.
    Urol Oncol. 2020 Jul 16. pii: S1078-1439(20)30291.
    PubMed         Abstract available

    World J Urol

  40. NASPRO R, Finati M, Roscigno M, Pellucchi F, et al
    The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre.
    World J Urol. 2020 Jul 21. pii: 10.1007/s00345-020-03364.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.